☆ 4.7 Article

Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

1,25-dihydroxyvitamin D as Predictor of Renal Worsening Function in Chronic Kidney Disease. Results From the PASCaL-1,25D Study

Andrea Galassi et al.

Summary: This study aimed to investigate the ability of 1,25(OH)(2)D to predict PTH increase and WRF in CKD stage 3-4. The results showed that lower levels of 1,25(OH)(2)D independently predicted the absolute increase in PTH, while higher levels of 1,25(OH)(2)D were associated with a reduced risk of WRF. The 1,25(OH)(2)D/PTH (1-84) ratio may serve as a composite biomarker of tubular reserve/endocrine response in CKD-MBD.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism

Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?

Alessandro Brancatella et al.

Summary: This study compared the clinical and biochemical features of heterozygous carriers of CYP24A1 variant with healthy wild-type controls. Heterozygotes exhibited a distinct biochemical phenotype compared to wild-type subjects, potentially requiring surveillance for the risk of developing hypercalcemia and related clinical manifestations when exposed to triggering factors.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Endocrinology & Metabolism

Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling

Martin Kaufmann et al.

Summary: In this study, using precision vitamin D metabolite profiling, researchers identified unique vitamin D metabolism profiles in some patients with idiopathic hypercalcemia (IH) and Williams-Beuren syndrome (WBS), suggesting hypersensitive expression of vitamin D-dependent genes as a potential mechanism of hypercalcemia in these patients. Normalization of serum calcium and vitamin D metabolites in an IH patient at follow-up indicates that symptomatic IH may be related to vitamin D nutritional status. This work highlights the importance of serum vitamin D metabolite profiling in differential diagnosis of vitamin D-related hypercalcemia and guiding appropriate treatment.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Add to Collection

Article Endocrinology & Metabolism

Mild Idiopathic Infantile Hypercalcemia-Part 2: A Longitudinal Observational Study

Nina Lenherr-Taube et al.

Summary: Idiopathic infantile hypercalcemia is a rare disorder with variable clinical features and the response to dietary calcium and vitamin D restriction in mild cases is not able to consistently normalize elevated 1,25(OH)2D concentrations or prevent worsening of renal calcification. Therapeutic options should focus on the defect in vitamin D metabolism.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient Cyp27b1 pseudo-null mouse

Mark B. Meyer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

A chromatin-based mechanism controls differential regulation of the cytochrome P450 gene Cyp24a1 in renal and non-renal tissues

Mark B. Meyer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Add to Collection

Article Medicine, Research & Experimental

CYP3A4 mutation causes vitamin D-dependent rickets type 3

Jeffrey D. Roizen et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Add to Collection

Article Endocrinology & Metabolism

Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)2D3 in Affected Patients

Martin Kaufmann et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2017)

Add to Collection

Article Endocrinology & Metabolism

CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations

Colin Patrick Hawkes et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Add to Collection

Article Biochemistry & Molecular Biology

CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations

Thomas O. Carpenter

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)

Add to Collection

Article Urology & Nephrology

Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia

Karl P. Schlingmann et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)

Add to Collection

Article Urology & Nephrology

Kidney Function and Influence of Sunlight Exposure in Patients With Impaired 24-Hydroxylation of Vitamin D Due to CYP24A1 Mutations

Marie-Lucile Figueres et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2015)

Add to Collection

Article Endocrinology & Metabolism

CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait

A. Molin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Add to Collection

Article Endocrinology & Metabolism

Clinical Utility of Simultaneous Quantitation of 25-Hydroxyvitamin D and 24,25-Dihydroxyvitamin D by LC-MS/MS Involving Derivatization With DMEQ-TAD

Martin Kaufmann et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Thematic Review Series: Fat-Soluble Vitamins: Vitamin D Cytochrome P450-mediated metabolism of vitamin D

Glenville Jones et al.

JOURNAL OF LIPID RESEARCH (2014)

Add to Collection

Article Pediatrics

Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene

Filip Fencl et al.

EUROPEAN JOURNAL OF PEDIATRICS (2013)

Add to Collection

Article Urology & Nephrology

Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation

Edgar Meusburger et al.

CLINICAL KIDNEY JOURNAL (2013)

Add to Collection

Article Endocrinology & Metabolism

The Importance of Measuring Ionized Calcium in Characterizing Calcium Status and Diagnosing Primary Hyperparathyroidism

Gregory S. Y. Ong et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Add to Collection

Article Pharmacology & Pharmacy

An Inducible Cytochrome P450 3A4-Dependent Vitamin D Catabolic Pathway

Zhican Wang et al.

MOLECULAR PHARMACOLOGY (2012)

Add to Collection

Article Medicine, General & Internal

Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia

Karl P. Schlingmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Pediatrics

Infantile Hypercalcemia and Hypercalciuria: New Insights into a Vitamin D-Dependent Mechanism and Response to Ketoconazole Treatment

Minh Nguyen et al.

JOURNAL OF PEDIATRICS (2010)

Add to Collection

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Review Medicine, General & Internal

Narrative review: Furosemide for hypercalcemia: An unproven yet common practice

Susan B. LeGrand et al.

ANNALS OF INTERNAL MEDICINE (2008)

Add to Collection

Review Critical Care Medicine

An official ATS statement: Hepatotoxicity of antituberculosis therapy

Jussi J. Saukkonen et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Add to Collection

Article Pharmacology & Pharmacy

Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1 alpha,25-dihydroxyvitamin D-3: Implications for drug-induced osteomalacia

Y Xu et al.

MOLECULAR PHARMACOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.